How to Detect and Prevent Contract Leakage in Pharmacy Purchasing
Hospital drug expenses increased 13.6% last year, outpacing nearly every other cost category, according to the American Hospital Association (AHA). Drug shortages reportedly added as much as 20% to hospital drug budgets in 2023 alone. Against that backdrop, contract leakage compounds the problem in ways that rarely trigger an obvious alert.
Contract leakage refers to spend lost through off-contract purchases, invoice overcharges, pricing misloads, missed rebate thresholds, and National Drug Code (NDC) level discrepancies. None of these failures announce themselves. They accumulate across thousands of transactions, often going undetected until a quarterly report surfaces the damage months after the fact.
Hospitals can manage 20,000 NDCs daily and face 10,000 weekly price updates. Manual oversight cannot keep pace with that volume. The result is a structural gap between the contracts health systems negotiate and the prices they actually pay.
What Contract Leakage Is Costing Health Systems
Pharmaceutical spend is one of the largest non-labor cost categories for hospitals. Drug expenditures at nonfederal hospitals reached $39 billion in 2024, according to data from the American Journal of Health-System Pharmacy (AJHP) and IQVIA. Leakage at even a small percentage of that figure translates to significant losses across a health system.
The Hidden Spend Problem
The scale of incorrect pricing in pharmacy purchasing is larger than most leaders realize. Roughly 2% of pharmacy spend is sheer overcharge, according to Pharmacy Times. That figure only becomes measurable when data and analytics are applied to the problem. Most health systems are still attempting to monitor spending manually with spreadsheets and wholesaler portals, which means the majority of overcharges go undetected and unpursued.
In pharma inventory management, the problem is compounded by fragmented data. Purchasing records sit across wholesaler systems, electronic health records, and dispensing cabinets, often with no unified view. Without integration, the true cost of leakage stays invisible until it shows up as a budget variance no one can fully explain.
Why It Goes Undetected
Most compliance problems in pharmacy purchasing surface through GPO or wholesaler reports that arrive 90 or more days after the purchase occurred. By that point, the context for the purchasing decision is gone, and correction is impossible. Buyer compliance failures are almost never a buyer problem. They are an information and alignment problem.
Pharmacy buyers are not randomly selecting products. When they purchase outside a contract, they typically have a reason: a shortage, a supply availability issue, a product substitution. The problem is that without real-time data, those decisions leave no traceable record, and the organization loses both the savings and the context to improve.
Manual invoice reconciliation cannot keep pace with weekly price changes. Errors accumulate silently across hundreds of line items, and the burden of catching them falls entirely on staff who already have full workloads.
The Three Primary Sources of Contract Leakage
Not all leakage originates in the same way. Understanding where it comes from is necessary to address it systematically.
Off-Contract Purchasing
Drug shortages are the most common driver of off-contract buying. More than 99% of hospital and health system pharmacists experienced drug shortages as recently as 2023, and purchasing outside contracted channels is a primary mitigation strategy.
Shortage-driven off-contract purchases are often clinically necessary. The compliance problem is not the purchase itself, but the absence of real-time tracking. When those transactions go unmonitored, they widen the gap between contracted and actual spend without any mechanism for review or correction.
Catching an off-contract purchase at the point of order means the team can stop it, return it, or document a legitimate exception. Catching it 90 days later means none of those options exist.
NDC-Level Pricing Discrepancies
Contracts are awarded at the NDC level, but invoice pricing frequently does not reflect the contracted rate. These errors, known as misloads, occur when contract information is not correctly loaded into a wholesaler’s ordering system. The buyer selects the right product but gets charged the wrong price, with no visibility into the discrepancy.
With 10,000 weekly price updates across 20,000 NDCs, manual tracking is functionally impossible. The discrepancies that surface are the ones large enough to catch the eye. The smaller ones, charged at scale across thousands of transactions, add up without detection.
The regulatory stakes are also rising. The Centers for Medicare and Medicaid Services (CMS) launched a Drug Acquisition Cost Survey in 2026, requiring hospitals to submit NDC-level pricing data for separately payable drugs. Accurate inventory management pharmacy-wide is no longer just a cost control matter. It is a compliance requirement with direct implications for reimbursement policy.
Invoice Errors and Overcharges
Hidden billing mistakes slip through unchecked invoices at a rate most health systems underestimate. GPO contract misloads, outlier account classifications, and pricing anomalies are among the most common sources of overcharges, and they are also among the least visible without automated monitoring.
The burden of detection currently falls on pharmacy staff. Without a system that flags errors automatically and routes them for review, most go unaddressed. The overcharge gets paid, the budget takes the hit, and the same error recurs on the next invoice.
How to Identify Leakage Patterns
Leakage rarely surfaces as a single obvious error. It shows up as a pattern of small discrepancies that compound over time across NDCs, facilities, and purchasing accounts. Pharmacy leaders who know what to look for can catch it earlier and quantify its impact before it becomes a budget problem with no clear origin.
These are the most common leakage signals to watch for in your purchasing data:
| Leakage Signal | What It Looks Like |
| Invoice price above contracted rate | The NDC has an active GPO or direct contract, but the invoiced price reflects WAC or a higher tier |
| Secondary wholesaler purchases on contracted items | A product with an active primary contract is being sourced through a secondary channel at a higher cost |
| Split volume across equivalent NDCs | Purchases are distributed across two or more NDCs for the same drug, preventing rebate tier thresholds from being reached on either |
| 340B-eligible purchases routed through WAC | A purchase qualifies for 340B pricing but was processed at wholesale acquisition cost, leaving savings on the table |
| Contract expiration price spikes | A price increase appears on an NDC after a contract lapses, with no alert and no substitute purchase flagged |
| Outlier account classifications | A purchasing account is miscategorized by class of trade, resulting in incorrect contract eligibility and pricing |
Each of these signals is detectable in purchasing and invoice data, but only if that data is unified and reviewed with enough frequency to catch discrepancies before they close. Many pricing errors carry manufacturer review windows as short as 30 days from invoicing. Once that window closes, the credit is gone regardless of fault.
Identifying leakage patterns also requires looking across facilities, not just within them. A discrepancy that appears minor at one site often indicates a systematic issue affecting the same NDC or contract across multiple locations. In pharma inventory management, site-level data that never gets consolidated is leakage that never gets found.
How to Monitor Contract Adherence in Real Time
The shift from retrospective to real-time contract monitoring is where health systems begin recovering spend that would otherwise stay lost. Monthly or quarterly GPO reports tell you what happened. Real-time monitoring gives you the opportunity to act before the loss is final.
Effective contract adherence monitoring covers four capabilities:
| Capability | What It Addresses |
| Anomalous price increase detection | Flags unexpected price changes before they process |
| Contract misload identification | Catches NDC-level pricing errors at the invoice stage |
| Invoice error notification | Routes billing discrepancies to the right staff for resolution |
| Nationwide pricing benchmarks | Compares your actual costs against what peer hospitals pay |
Bluesight’s CostCheck monitors 100% of contracts and invoices, catches overlooked invoice errors, and notifies users of mischarges before they become permanent. The platform averages up to $15,000 in savings per NDC substitution recommendation and is designed to deliver results in approximately 30 minutes per week.
In pharma inventory management terms, real-time monitoring requires data integration across wholesalers, health records, and dispensing systems. A fragmented data environment makes real-time visibility structurally impossible. Unifying those data streams is what gives pharmacy leaders an accurate, current picture of spend.
Preventing Leakage Across a Health System
Detection identifies the problem. Prevention stops it from recurring. These two goals require different interventions.
Standardize Purchasing Decisions Across Sites and Staff
Inconsistency is one of the most persistent leakage drivers in multi-site health systems. Different facilities purchase different products at different prices from different vendors, often without awareness of what peer sites are paying. Those gaps multiply at scale.
Integrated purchasing platforms replace informal workarounds with system-driven guidance. When buyers across all locations see the same contracted products, preferred NDCs, and pricing expectations, purchasing decisions align without requiring manual coordination. Staff get the right information at the point of purchase rather than after a compliance report arrives.
NDC consolidation also reduces operational complexity across inventory management and pharmacy workflows. Fewer active NDCs means more predictable volume, simpler storage requirements, cleaner accumulations for programs like the 340B Drug Pricing Program, and fewer discrepancies at the returns and expirations stage.
Build a Real-Time Accountability Loop
A real-time accountability loop changes the economics of purchasing errors. When a buyer purchases off-contract, a real-time alert surfaces the decision immediately. The team can review the reasoning, correct the order if appropriate, or document a legitimate exception. That feedback loop improves purchasing alignment over time without placing blame on individual buyers.
Health systems with a central decision-making body and real-time purchasing data consistently outperform those without one. The data creates shared visibility. The accountability loop creates shared accountability.
For health systems participating in the 340B Drug Pricing Program, real-time monitoring closes a specific and costly gap. Untracked 340B purchases erode program savings and expose covered entities to audit penalties. Bluesight’s 340BCheck integrates with CostCheck to give pharmacy leaders visibility into 340B compliance alongside broader purchasing performance.
What Good Contract Compliance Looks Like
Health systems with strong contract compliance share a few measurable characteristics. Pharmacy leaders can track performance against these benchmarks to assess where leakage risk is highest.
| Benchmark | Signal to Watch |
| GPO contract compliance rate | Percentage of purchases made on contracted products by facility and NDC |
| Invoice error rate | Volume of billing discrepancies flagged and resolved per period |
| Off-contract purchase rate | Frequency and dollar value of purchases outside contracted channels |
| Time to resolution | How quickly invoice errors and misloads are caught and corrected |
Operationally, pharmacy leaders should be able to review purchasing performance and act on savings opportunities in under 30 minutes per week. If that review requires pulling data from multiple systems, consolidating spreadsheets, or waiting on a report from a GPO or wholesaler, the process itself is creating the delay that allows leakage to continue.
The regulatory dimension is also worth tracking directly. CMS’s focus on NDC-level acquisition cost data means that the same visibility gaps that produce contract leakage can also create compliance exposure. Pharmacy purchasing accuracy is no longer a back-office concern. It affects reimbursement, audit risk, and the financial viability of programs that health systems depend on.
Contract leakage accumulates quietly, through pricing errors that never get flagged, off-contract purchases that never get reviewed, and invoice overcharges that never get disputed. Health systems that move from retrospective reporting to real-time monitoring recover spend that would otherwise stay lost and build the operational foundation to keep it from recurring.
See how CostCheck works and learn what real-time pharmacy purchasing optimization looks like in practice.